首页> 外文期刊>British journal of ophthalmology >Reduction in screening for retinopathy of prematurity through risk factor adjusted inclusion criteria
【24h】

Reduction in screening for retinopathy of prematurity through risk factor adjusted inclusion criteria

机译:通过风险因素调整的纳入标准减少对早产儿视网膜病变的筛查

获取原文
获取原文并翻译 | 示例
           

摘要

Aims: To develop a new national screening guideline for retinopathy of prematurity (ROP). Methods: Included were infants of the 2009 prospective ROP inventory in The Netherlands with gestational age (GA) <32 weeks and/or birth weight (BW) <1500 g. Five models were studied, based on GA and BW in combination with no, one or a set of five risk factors for ROP. Risk factors were determined by logistic regression. In MEDLINE and EMBASE, additional risk factors were searched. A precondition was that no infants with severe ROP would be missed. Receiver operating characteristic curves or classical measures were used to determine diagnostic accuracy. Results: The model including all infants with severe ROP comprised screening of infants with GA <30 weeks and/or BW <1250 g and a selection of infants with GA 30-32 weeks and/or BW 1250-1500 g, with at least one of the following risk factors: artificial ventilation (AV), sepsis, necrotising enterocolitis (NEC), postnatal glucocorticoids or cardiotonica. This model would not detect 4.8% (95% CI 2.5% to 8.0%) of infants with mild ROP and would reduce infants eligible for screening by 29%. Conclusions: In The Netherlands, screening may be safely reduced using a new guideline based on GA, BW, AV, sepsis, NEC, postnatal glucocorticoids and cardiotonica.
机译:目的:为早产儿视网膜病变(ROP)制定新的国家筛查指南。方法:包括荷兰2009年前瞻性ROP清单中的婴儿,其胎龄(GA)<32周和/或出生体重(BW)<1500 g。研究了基于GA和BW的五个模型,没有,没有一个或一组五个ROP危险因素。危险因素通过逻辑回归确定。在MEDLINE和EMBASE中,还搜索了其他风险因素。前提条件是不会错过任何严重ROP的婴儿。使用接收器工作特性曲线或经典测量来确定诊断准确性。结果:该模型包括所有患有严重ROP的婴儿,包括筛查GA <30周和/或BW <1250 g的婴儿,以及选择GA 30-32周和/或BW 1250-1500 g的婴儿,并至少选择一个下列危险因素之一:人工通气(AV),败血症,坏死性小肠结肠炎(NEC),产后糖皮质激素或心律失常。该模型无法检测出4.8%(95%CI 2.5%至8.0%)的轻度ROP婴儿,而有资格进行筛查的婴儿减少了29%。结论:在荷兰,可以使用基于GA,BW,AV,脓毒症,NEC,产后糖皮质激素和强心剂的新指南安全地减少筛查。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号